K Health | $50,000,000 | (Jul 2, 2024)
N-Power Medicine, Inc. | Undisclosed Amount | (Jul 2, 2024)
Pieces for Developers | $13,500,000 | (Jul 2, 2024)
Triastek, Inc.
China
- Nanjing, Jiangsu
- 10/10/2023
- Pre-Series C
- $20,400,000
Triastek is a global leader in 3D printing pharmaceuticals, pioneering the next generation of digital pharmaceutical processes.
Founded in July 2015, Triastek is dedicated to the mission of "revolutionizing the pharmaceutical industry, unlocking the next generation of medicine and benefitting patients worldwide." We have created the Melt Extrusion Deposition (MED®) 3D printing pharmaceutical process, transforming the delivery, development, and production of medication through digital product development and continuous manufacturing.
Leveraging our proprietary 3D printing pharmaceutical technology, we design and develop transformative medications for patients. Through collaboration with global pharmaceutical companies, we tackle challenging formulation issues, accelerating the development of new drug products and improving the quality of pharmaceuticals.
Our vision is to become the world's most influential intelligent pharmaceutical enterprise.
- Industry Pharmaceutical Manufacturing
- Website https://www.triastek.com/indexen.html
- LinkedIn https://www.linkedin.com/company/triastek-inc/about/
Supercede | The Reinsurance Platform | $15,000,000 | (Jun 28, 2024)
AuthZed | $12,000,000 | (Jun 28, 2024)
Smartworks | $12,000,000 | (Jun 28, 2024)
Synthflow AI | $7,400,000 | (Jun 28, 2024)
Odaseva | $54,000,000 | (Jun 28, 2024)
KarmaCheck | $45,000,000 | (Jun 28, 2024)
Dodona Analytics | Undisclosed Amount | (Jun 28, 2024)
Ginossar Ventures | $13,000,000 | (Jun 28, 2024)